Autologous and Allogeneic Blood Stem Cell Transplantation: Potential Advantage of Blood- over Marrow-Derived Stem Cell Grafts

References

• Fliedner T M, Calvo W, Korbling M, Kreutzmann H, Nothdurft W, Ross W, Vassileva D. Hemalopoielic stem cells in blood: Characteristics and potentials. ICN-UCLA Symposia on Molecular Biology, M J Cline, D Metcalf, F Fox, 1978; 193–212
   Google Scholar
• Fliedner T M, Steinbach K H. Repopulating potential of hematopoietic precursor cells. Blood Cells 1988; 14: 393–410
   PubMedGoogle Scholar
• Baum C M, Uchida N, Peault B, Weissman I L. Isolation and characterization of hematopoietic progenitor and stem cells. Bone Marrow Transplantation, S J Foreman, K G Blume, E D Thomas. Blackwell Scientific Publications. 1994; 53–71
   Google Scholar
• Bender J G, Unverzagt K, Walker D E, Lee W, Smith S, Williams S, Van Epps D E. Phenotypic analysis and characterization of CD34 cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem ceil transplantation. Clin Immunol Immunopathol 1994; 70: 10–18
   PubMedGoogle Scholar
• Kukuda T, Okamura S, Shimoda K, Takamatsu Y, Inaba S, Harada M, Niho Y. Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor. Eur J Haematol 1994; 52: 201–206
   PubMed Web of Science ®Google Scholar
• Bender J G, Unverzagt K L, Walker D E, Lee W, Van Eppe D E, Smith D H, Stewart C C, To L B. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77: 2591–2596
   PubMed Web of Science ®Google Scholar
• Tjonnfjord G E, Steen R, Evensen S A, Thorsby E, Egeland T. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994; 84: 2795–2801
   PubMed Web of Science ®Google Scholar
• To L B, Shepperd K M, Haylock D N, et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990; 18: 442–447
   PubMed Web of Science ®Google Scholar
• Brugger W, Bross K, Frisch J, et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 1992; 79: 1193–1200
   PubMed Web of Science ®Google Scholar
• Sheridan W P, Begley C G, Juttner C A, et al. Effect of peripheral-blood progenitor cells mobilized by filgrastin (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640–644
   PubMed Web of Science ®Google Scholar
• Peters W, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709–1719
   PubMed Web of Science ®Google Scholar
• Bensinger W I, Price T H, Dale D C, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883–1888
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Sakamaki S, Kohgo Y, Ohi S, Hirayama Y, Niitsu Y. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103–108
   PubMed Web of Science ®Google Scholar
• Molineux G, Pojda Z, Hampson I N, Lord B I, Dexter T M. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990; 76: 2153–2158
   PubMed Web of Science ®Google Scholar
• Tong J, Gordon M S, Srour E F, Cooper R J, Orazi A, McNiece I, Hoffman R. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 1993; 82: 784–791
   PubMed Web of Science ®Google Scholar
• McNiece I K, Briddell R A, Hartley C A, Andrews R G. The role of stem cell factor in mobilization of peripheral blood progenitor cells: Synergy with G-CSF. Stem Cells 1993; 1l(Suppl 3)83–88
   Google Scholar
• Andrews R G, Bensinger W I, Knitter G H, et al. The ligand for c-kit, stem cell factor (SCF), stimulates the circulation of cells thai engraft lethally irradiated baboons. Blood 1992; 80: 2715–2720
   PubMed Web of Science ®Google Scholar
• Hillyer C D, Tiegerman K O, Berkman E M. Increase in circulating colony-forming units-granulocyle-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991; 31: 327–332
   PubMed Web of Science ®Google Scholar
• Korbling M, Fliedner T M, Pflieger H. Collection of large quantities of granulocyte/macrophage progenitor cells (CFUc) in man by means of continuous-flow leukapheresis. Scand J Haematol 1980; 24: 22–28
   PubMedGoogle Scholar
• Malachowski M E, Comenzo R L, Hillyer C D, Tiegerman K O, Berkman E M. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992; 32: 732–735
   PubMed Web of Science ®Google Scholar
• Comenzo R I, Malachowski M E, Miller K B, et al. Engraflment with peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma. Transfusion 1992; 32: 729–731
   PubMed Web of Science ®Google Scholar
• Passos-Coelho J L, Braine H G, Wright S K, et al. Large volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells (PBPC). J Hematother
   Google Scholar
• Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 78: 400–409
   Google Scholar
• Shpall E J, Jones R B, Bearman S I, et al. Transplantation of enriched CD34-posilive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28–36
   PubMed Web of Science ®Google Scholar
• Moss T J, Sanders D G, Lasky L C, Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990; 76: 1879–1883
   PubMed Web of Science ®Google Scholar
• Moss T J, Ross A A. The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematother 1992; 1: 225–232
   PubMedGoogle Scholar
• Ross A A, Cooper B W, Lazarus H M, Ciobanu N, et al. Immunocy-tologic detection of tumor cells in peripheral blood stem cell (PBSC) collections of breast cancer patients. Breast Cancer Res Treat 1991; 19: 171
   Google Scholar
• Sharp J G, Kessinger A, Vaughan W P, Mann S, et al. Detectionand clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Cloning 1992; 10(Suppl I)92–94
   Google Scholar
• Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636–640
   PubMed Web of Science ®Google Scholar
• Franklin W A, Shpall E J, Archer P, Johnston C S, Garza-Williams S, Hami L, Bitter M A, Bast R C, Jones R B. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Cancer 1994, in press
   Web of Science ®Google Scholar
• Dalta Y H, Adams P T, Drobyski W R, Ethier S P, Terry V H, Roth M S. Sensitive detection of occult breast cancer by the reverse-tran-scriptase polymerase chain reaction. J Clin Oncol 1994; 12: 475–482
   PubMed Web of Science ®Google Scholar
• Hardingham J E, Kotasek D, Sage R E, Dobrovic A, Gooley T, Dale B M. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993; 11: 15–20
   PubMed Web of Science ®Google Scholar
• Pilarski L M, Jensen G S. Monoclonal circulating B cells in multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 297–322
   PubMed Web of Science ®Google Scholar
• Berenson J, Wong R, Kim K, Brown N, Lichtenstein A. Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• Levy Y, Schmitl C, Tsapis A, et al. Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol 1991; 84: 435
   PubMed Web of Science ®Google Scholar
• Körbling M, Burke P, Braine H, Elfenbein G, Santos G, Kaizer H. Successful engraftment of blood derived normal hemopoietic stem cells in chrome myelogenous leukemia. Exp Hematol 1981; 9: 684–690
   PubMed Web of Science ®Google Scholar
• Carella A M, Podesta M, Frassoni F, et al. Collection of ‘normal’ blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267–271
   PubMed Web of Science ®Google Scholar
• Kanlarjian H M, Talpaz M, Hester J, Feldman E, Korbling M, Liang J, Rios M B, Calvert L, Deisseroth A B. Collection of peripheral blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive dose chemotherapy. J Clin Oncol, submitted to
   Google Scholar
• Gribben J G, Freedman A S, Neuberg D, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Brenner M K, Rill D R, Moen R C, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85–86
   PubMed Web of Science ®Google Scholar
• Palathumpat V, Strang G, Zeitung J, Van Vlasselaer P. Enrichment of committed and uncommitted human hematopoietic progenitor cells using the density gradient based Simplesep enrichment system. Blood, Proc ASH 1994
   Google Scholar
• Strang G, Palathumpat V, Zeitung J, Hung P L, Van Vlasselaer P. Characterization of natural suppressor cell activity in peripheral blood of G-CSF mobilized healthy volunteers. Blood, Proc ASH 1994
   Google Scholar
• Negrin R S, Kusnierz-Glaz C R, Still B J, Schribner J R, Chao N J, Long G D, Hovle C, Hu W W, Homing S J, Brown B W, Blume K G, Strober S. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkins lymphoma (NHL). Blood, Proc ASH 1994
   Google Scholar
• Deisseroth A B, Zhifei Z, Claxton D, et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068–3076
   PubMed Web of Science ®Google Scholar
• Verfaillie C M, Miller W J, Boylan K, et al. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 1992; 79: 1003–1010
   PubMed Web of Science ®Google Scholar
• Baum C M, Weissman I L, Tsukamoto A S, Buckle A M, Peault B. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 1992; 89: 2804–2808
   PubMed Web of Science ®Google Scholar
• Korbling M, Drach J, Champlin R, Engel H, Huynh L, Kleine H D, Berenson R, Deisseroth A, Andreeff M. Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR” hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: Implications for gene transduction and/or transplantation. Bone Marrow Transplant 1994; 13: 649–654
   PubMed Web of Science ®Google Scholar
• Moore K A, Deisseroth A B, Reading C, Williams D E, Bemont J W. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 1992; 79: 1393–1399
   PubMed Web of Science ®Google Scholar
• Bamett M J, Eaves C J, Phillips G L, et al. Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplant 1989; 4: 345–351
   PubMed Web of Science ®Google Scholar
• Palsson B O, Paek S H, Schwartz R M, Palsson M, Lee G M, Silver S, Emerson S G. Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnology 1993; 11: 368–371
   PubMed Web of Science ®Google Scholar
• Emerson S G. Personal communication. 1994
   Google Scholar
• Koller M R, Emerson S G, Palsson B O. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993; 82: 378–384
   PubMed Web of Science ®Google Scholar
• Haylock D N, To L B, Dowse T L, et al. Ex vivo expansion and maturation of peripheral blood CD34 cells into the myeloid lineage. Blood 1992; 80: 1405–1412
   PubMed Web of Science ®Google Scholar
• Sato N, Sawada K, Koizumi K, et al. In vitro expansion of human peripheral blood CD34+ cells. Blood 1993; 82: 3600–3609
   PubMed Web of Science ®Google Scholar
• Brugger W, Mocklin W, Heimfeld S, Berenson R, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-lβ (II-lβ), 11–6,11–3, Interferon-γ, and erythropoietin. Blood 1993; 81: 2579–2584
   PubMed Web of Science ®Google Scholar
• Rill D R, Moen R C, Buschle M, Bartholomew C, Foreman N K, Mirro J, Jr, Krance R J, Ihle J N, Brenner M K. An approach for the analysis of relapse and marrow reconstitution following autologous marrow transplantation using retrovirus mediated gene transfer. Blood 1992; 79: 2694–2700
   PubMed Web of Science ®Google Scholar
• Rill D R, Buschle M, Foreman N K, Bartholomew C, Moen R C, Santana V M, Ihle J N, Brenner M K. Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene Ther 1992; 3: 129–136
   PubMed Web of Science ®Google Scholar
• Miller A R, Skotzko M J, Rhoades K, Belldegrun A S, Tso C L, Kaboo R, McBride W H, Jacobs E, Kohn D B, Moen R, Economou J S. Simultaneous use of two retroviral vectors in human gene marking trials: Feasibility and potential applications. Hum Gene Ther 1992; 3: 619–624
   PubMed Web of Science ®Google Scholar
• Hanania E G, Fu S, Zu Z, Hegewisch-Becker S, Korbling M, Andreeff M, Mechetner E, Roninson I, Giles R, Berenson R, Heimfeld S, Deisseroth A B. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus which contains the MDR-1 chemotherapy resistance gene. Gene Ther
   Web of Science ®Google Scholar
• Körbling M, Przepiorka D, Engel H, van Besien K, Giralt S, Andersson B, Huh Y O, Kleine H D, Seong D, Deisseroth A B, Andreeff M, Champlin R. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood
   Google Scholar
• Schmidt-Wolf I GH, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S. T-cell subsets and suppressor cells in human bone marrow. Blood 1992; 80: 3242–3250
   PubMed Web of Science ®Google Scholar
• Micklem H S, Anderson N, Ross E. Limited potential of circulating haemopoietic stem cells. Nature 1975; 256: 41–43
   PubMed Web of Science ®Google Scholar
• Körbling M, Dorken B, Ho A, et al. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986; 67: 529–532
   PubMed Web of Science ®Google Scholar
• Körbling M, Fliedner T M, Holle R, et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: Influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991; 7: 343–349
   PubMed Web of Science ®Google Scholar
• Laporte J P, Gorin N C, Feuchtenbaum J, Lopez M, Douay L, Lyon-Caen D, Du Puy H, Montbrun M C, Lemonnier M P, Isnard F, Najman A. Relapse after autografting with peripheral blood stem cells. Lancet 1987; 2: 1393, (letter)
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Singhal S, Treleaven J. Peripheral blood stem cell transplantation may result in increased relapse of acutemyeloid leukemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant
   Web of Science ®Google Scholar
• Reiffers J. Personal communication. 1994
   Google Scholar
• Dimopoulos M A, Alexanian R, Przepiorka D, Hester J, Andersson B, Giralt S, Mehra R, van Besien K, Delasalle K B, Reading C, Deisseroth A B, Champlin R E. Thiotepa, Busulfan and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 1993; 82: 2324–2328
   PubMed Web of Science ®Google Scholar
• Tepler I, Cannistra S A, Frei E, III, Gonin R, Anderson K C, Demetri G, Niloff J, Goodman H, Muntz H, Muto M, Dheets E, Elias A D, Mazanet R, Wheeler C, Ayash L, Schwartz G, McCauley M, Gaynes L, Harvey S, Schnipper L E, Antman K H. Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. J Clin Oncol 1993; 11: 1583–1591
   PubMed Web of Science ®Google Scholar
• Kesstnger A, Smith D M, Strandjord S E, Landmark J D, Dooley D C, Law P, Coccia P F, Warkentin P I, Weisenburger D D, Armitage J O. Allogeneic transplantation of blood-derived, T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643–646
   PubMed Web of Science ®Google Scholar
• Russell N H, Hunter A, Rogers S, Hanley J, Anderson D. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482, (letter)
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Sakamaki S, Kongo Y, Ohi S, Hirayama Y, Niitsu Y. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103–108
   PubMed Web of Science ®Google Scholar
• Dreger P, Suttorp M, Haferlach T, Loffler H, Schmitz N, Schroyens W. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404–1407
   PubMed Web of Science ®Google Scholar
• Weaver C H, Buckner C D, Longin K, Appelbaum F R, Rowley S, Lilleby K, Miser J, Storb R, Hansen J A, Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981–1984
   PubMed Web of Science ®Google Scholar
• Nemunaitis J, Albo V, Zeigler Z R, Shadduck R K, Rosenfeld C S. Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells. Leuk Lymphoma 1993; 10: 405–406
   PubMed Web of Science ®Google Scholar
• Engel H, Korbling M, Palmer J, Mehra R, Walker J, Andreeff M, Champlin R. Randomized trial of G-CSF alone vs sequential Inter-leultin-3 (IL-3) and G-CSF treatment to peripheralize progenitor cells for apheresis and blood stem cell autotransplantation in patients with advanced stage breast cancer. Blood 1994; 84(SuppI l)108a
   Google Scholar
• Kaushansky K, Lin N, Fox N, Jorgensen M, McCarty J, Lofton-Day C, Zucker-Franklin D, Broudy V C. Thrombopoietin (Tpo), the MPL ligand, is the primary regulator of megakaryocyte (Mk) development and maturation. Blood 1994; 84(Suppl l)241a
   Google Scholar